CAH vs. SOLV: Cardinal Health vs. Solventum Stock Comparison

Company Profile

Cardinal Health (CAH) and Solventum (SOLV) both fall under the Health Care Equipment & Services industry group, but CAH is classified in Health Care Providers & Services while SOLV is classified in Health Care Equipment & Supplies.

Cardinal Health (CAH) carries decades of public-market history since August 4, 1983, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the CAH side.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: Solventum (SOLV) earns 3.19% on shareholders’ equity, ranked against its industry; Cardinal Health (CAH) has no ROE this period.

Both Cardinal Health (CAH) at 0.71% and Solventum (SOLV) at 1.91% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both Cardinal Health (CAH) at 1.34% and Solventum (SOLV) at 6.82% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Cardinal Health (CAH) at 14.23% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Solventum (SOLV) at 221.74% clears its industry range for EPS growth, a much stronger earnings trajectory than Cardinal Health (CAH) at 12.09%, which is closer to a typical peer reading.

Growth Metrics

Financial Strength

Both Cardinal Health (CAH) at 0.89 and Solventum (SOLV) at 1.03 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Only one side’s leverage can be read here: Solventum (SOLV) carries debt-to-equity ratio of 1.10 against its industry range, while Cardinal Health (CAH) reports no figure this period.

Financial Strength Metrics

Dividends

Solventum (SOLV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cardinal Health (CAH) reports a yield of 0.77%, ranking against industry peers normally.

Solventum (SOLV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cardinal Health (CAH) reports a payout of 26.56%, ranking against industry peers normally.

Dividend Metrics

Valuation

Cardinal Health (CAH) at 35.15 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.

Cardinal Health (CAH) at 0.24 sits in the cheaper P/S ratio quartile while Solventum (SOLV) at 1.88 prices around its industry’s middle — CAH costs less per dollar of sales, though read it alongside growth and margins.

Cardinal Health (CAH) reports a negative P/B ratio of -20.84, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Solventum (SOLV) reports 3.20, ranking against industry peers normally.

Valuation Metrics